knowcompoundsN(5)-ethyl-L-glutamine
Specimen compound organic compoundPlate I
L- theanine

- Formula
- C7H14N2O3
- Molar mass
- 174.2 g/mol
- ChEBI
- CHEBI:17394
- PubChem CID
- 439378
- InChIKey
- DATAGRPVKZEWHA-YFKPBYRVSA-N
↓ lowered 4 findings in 4 endpoints · – no difference found 1 in 1
01 · the evidence, ordered
What the evidence says
- Strong
- 0
- Moderate
- 0
- Limited
- 1
- Very limited
- 4
- Insufficient
- 0
L-theanine
Most findings
- Insomnia Severity Index (ISI) total score×1
- Isometric peak force×1
- PANSS general psychopathology subscale score×1
- PANSS positive subscale score×1
- Yale-Brown Obsessive Compulsive Scale (Y-BOCS) total score×1
5 compounds on the outer ring, not drawn
Keys
← → round a ring↑ ↓ out and inEnter selecte the outer ringf fit to view+ − zoomEsc clearclick a node to select it
- Isometric peak force
- Insomnia Severity Index (ISI) total score
- PANSS general psychopathology subscale score
- PANSS positive subscale score
- Yale-Brown Obsessive Compulsive Scale (Y-BOCS) total score
02 · findings
What L-theanine moved, and by how much
- Dose studied: as its paper gave it.
- Evidence strength: computed from the study. How it is computed
5 shown
- Isometric peak forceMoved: lowersEvidence: LimitedPaper: PMID 416687202025
- Who
- 20 young competitive athletes (12 male, 8 female), four-condition randomized double-blind crossover; theanine alone versus mannitol placebo; leg and back isometric strength by dynamometer
- Dose studied
- 200 mg L-theanine capsules, single dose 60 min before testing
In contrast, L-theanine was associated with lower leg and back strength values compared with placebo, indicating a negative effect on maximal isometric force production.”
Quoted verbatim from Acute effects of combined and isolated caffeine and theanine supplementation on physical and cognitive performance in competitive athletes: a randomized, double-blind, placebo-controlled crossover study.crossoverPermalink - Insomnia Severity Index (ISI) total scoreMoved: no difference foundEvidence: Very limitedPaper: PMID 305800812019
- Who
- Adults with DSM-5 generalized anxiety disorder, all on stable antidepressant treatment in both arms
- Dose studied
- adjunctive L-theanine 450-900 mg
Results revealed that adjunctive L-theanine did not outperform placebo for anxiety reduction on the HAMA (p = 0.73) nor insomnia severity on the Insomnia Severity Index (ISI; p = 0.35).”
Quoted verbatim from L-theanine in the adjunctive treatment of generalized anxiety disorder: A double-blind, randomised, placebo-controlled trial.RCT · 8 weeksPermalink - PANSS positive subscale scoreMoved: lowersEvidence: Very limitedPaper: PMID 212085862011
- Who
- Chronic schizophrenia or schizoaffective disorder (DSM-IV); antipsychotic treatment continued in both arms as background; 8-week 2-center trial; PANSS 3-dimensional model
- Dose studied
- L-theanine 400 mg/d added to ongoing antipsychotic
Compared with placebo, L-theanine augmentation was associated with reduction of anxiety (P = .015; measured by the HARS scale) and positive (P = .009) and general psychopathology (P < .001) scores (measured by the PANSS 3-dimensional model).”
Quoted verbatim from L-theanine relieves positive, activation, and anxiety symptoms in patients with schizophrenia and schizoaffective disorder: an 8-week, randomized, double-blind, placebo-controlled, 2-center study.RCT · 8 weeksPermalink - PANSS general psychopathology subscale scoreMoved: lowersEvidence: Very limitedPaper: PMID 212085862011
- Who
- Chronic schizophrenia or schizoaffective disorder (DSM-IV); antipsychotic treatment continued in both arms as background; 8-week 2-center trial; PANSS 3-dimensional model
- Dose studied
- L-theanine 400 mg/d added to ongoing antipsychotic
Compared with placebo, L-theanine augmentation was associated with reduction of anxiety (P = .015; measured by the HARS scale) and positive (P = .009) and general psychopathology (P < .001) scores (measured by the PANSS 3-dimensional model).”
Quoted verbatim from L-theanine relieves positive, activation, and anxiety symptoms in patients with schizophrenia and schizoaffective disorder: an 8-week, randomized, double-blind, placebo-controlled, 2-center study.RCT · 8 weeksPermalink - Yale-Brown Obsessive Compulsive Scale (Y-BOCS) total scoreMoved: lowersEvidence: Very limitedPaper: PMID 371695152023
- Who
- Adults 18-60 with DSM-5 OCD and baseline Y-BOCS above 21; fluvoxamine given to both arms as background (100 mg daily, 200 mg daily after week 5); 10-week parallel-group trial; primary outcome was Y-BOCS total decrease from baseline; result recorded is the week-10 contrast
- Dose studied
- L-theanine 100 mg twice daily, oral, added to fluvoxamine
Also, total Y-BOCS scores were lower in L-theanine compared to placebo group at week 5 (P = 0.039, Cohen's d = 0.60) and 10 (P = 0.008, Cohen's d = 0.80).”
Quoted verbatim from L-theanine combination therapy with fluvoxamine in moderate-to-severe obsessive-compulsive disorder: A placebo-controlled, double-blind, randomized trial.RCT · 2 monthsPermalink
No row matches these filters.
No dose is advised.
- Dose studied: as its paper gave it.
- Evidence strength: computed from the study. How it is computed
03 · identity
Structure
- Charge
- 0
- SMILES
- CCNC(=O)CC[C@H](N)C(=O)O
What the reference databases state
- Reactions · Rhea
- 2reactions
2Reactions
05 · on the label · 2,090 products
Labelled products
Source: NIH DSLD · Ingredient: N(5)-ethyl-L-glutamine · 2,090 products · Declared amount per serving (the first 1,000 shown): 1–1,000 mg
747 labels of the first 1,000 shown state an amount253 do not
- 1 BodyBrain Support100 mgper 3 capsulesDSLD:257246
- 1st PhormRoyal XXI Kingamount not statedper 1 capsuleDSLD:211507
- 1st PhormRoyal XXI Queenamount not statedper 1 capsuleDSLD:211508
- 21st CenturyBrilliant Brain100 mgper 2 tabletsDSLD:205530
- 4 OrganicsAppetite Awayamount not statedper 1 capsuleDSLD:26218
- 4 OrganicsAppetite Awayamount not statedper 1 capsuleDSLD:268146
- 4 OrganicsAppetite Awayamount not statedper 1 capsuleDSLD:268147
- 4 OrganicsJumpstart Boost Formula EXamount not statedper 1 capsuleDSLD:268152
- 4 OrganicsJumpstart Boost Formula EXamount not statedper 1 capsuleDSLD:268153
- 4 OrganicsSerene Relaxation/Sleep Supportamount not statedper 2 capsulesDSLD:268158
- 4 OrganicsSerene Relaxation/Sleep Supportamount not statedper 2 capsulesDSLD:268159
- 8WeeksOutIntellect250 mgper 3 capsulesDSLD:228495
Show the remaining 2,078Show the first 12
Label record: NIH Office of Dietary Supplements · CC0
06 · the record
Sources
102
papers screened for L-theanine
- admitted
- 6
- read and discarded
- 41
- not read yet
- 55
Sources cited
4 papers · 5 findings
2 admitted at screening, no finding yet